VOLPE, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 327
EU - Europa 208
AS - Asia 84
AF - Africa 20
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 643
Nazione #
US - Stati Uniti d'America 322
IT - Italia 127
SG - Singapore 64
NL - Olanda 34
CI - Costa d'Avorio 19
IE - Irlanda 14
CN - Cina 13
GB - Regno Unito 7
DE - Germania 5
UA - Ucraina 5
CA - Canada 4
FI - Finlandia 4
SE - Svezia 4
AR - Argentina 2
FR - Francia 2
IN - India 2
PL - Polonia 2
PT - Portogallo 2
TH - Thailandia 2
AU - Australia 1
EU - Europa 1
GR - Grecia 1
ID - Indonesia 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
PK - Pakistan 1
RO - Romania 1
Totale 643
Città #
Ashburn 58
Singapore 51
Naples 46
Chandler 43
Amsterdam 34
Santa Clara 29
Napoli 17
Lawrence 13
Dublin 12
Boston 9
Des Moines 9
Millbury 8
Washington 8
Los Angeles 6
Milan 5
Wilmington 5
Woodbridge 5
Houston 4
Bradford 3
Fairfield 3
Florence 3
Jacksonville 3
Lappeenranta 3
Menlo Park 3
Villaricca 3
Alges 2
Cambridge 2
Chiang Mai 2
Cipolletti 2
Ottaviano 2
Seattle 2
Ann Arbor 1
Beijing 1
Boardman 1
Caivano 1
Casablanca 1
Casavatore 1
Casoria 1
Catania 1
Dallas 1
Denpasar 1
Ercolano 1
Formia 1
Galati 1
Gdansk 1
Helsinki 1
Ischia 1
Kronberg 1
Kuala Lumpur 1
Kunming 1
Lahore 1
Mugnano di Napoli 1
Nanjing 1
Negrar 1
Nogales 1
Nuremberg 1
Orta di Atella 1
Piraeus 1
Rome 1
San Francisco 1
Sunnyvale 1
Trecase 1
Warsaw 1
Totale 427
Nome #
Management of differentiated thyroid cancer through nuclear medicine facilities during Covid-19 emergency: the telemedicine challenge 60
Ablation rate after radioactive iodine therapy in patients with differentiated thyroid cancer at intermediate or high risk of recurrence: a systematic review and a meta-analysis 50
Quantification of Coronary Artery Atherosclerotic Burden and Muscle Mass: Exploratory Comparison of Two Freely Available Software Programs 49
Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone 40
Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer 40
Whole-body radioiodine effective half-life in patients with differentiated thyroid cancer 39
Identification and typing of cardiac amyloidosis by noninvasive imaging: Two cases for two patterns 37
Risk of structural persistent disease in pediatric patients with low or intermediate risk differentiated thyroid cancer 34
The diagnostic role of total-body 18F-FDG PET/CT in patients with multiple tumors: a report of the association of thyroid cancer with lung or renal tumors 31
Prognostic value of heart rate reserve in patients with suspected coronary artery disease undergoing stress myocardial perfusion imaging 30
Prognostic Value of Hybrid PET/MR Imaging in Patients with Differentiated Thyroid Cancer 30
Risk of primary breast cancer in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a systematic review and meta-analysis 29
Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms 27
Long-term prognostic value of the response to therapy assessed by laboratory and imaging findings in patients with differentiated thyroid cancer 27
Initial Testing of an Approximated, Fast Calculation Procedure for Personalized Dosimetry in Radionuclide Therapy Based on Planar Whole-Body Scan and Monte-Carlo Specific Dose Rates from the OpenDose Project 25
Intramedullary Spinal Cord Metastases from Differentiated Thyroid Cancer, a Case Report 24
Second Primary Malignancies in Patients with Differentiated Thyroid Cancer after Radionuclide Therapy: A Retrospective Single-Centre Study 23
Tumor Burden of Iodine-Avid Bone Metastatic Thyroid Cancer Identified via 18F-Sodium Fluoride PET/CT Imaging 16
Efficacy of Empirical Radioiodine Therapy in Patients with Differentiated Thyroid Cancer and Elevated Serum Thyroglobulin without Evidence of Structural Disease: A Propensity Score Analysis 14
Prognostic value of 12-month response to therapy in pediatric patients with differentiated thyroid cancer 14
Emerging Role of Nuclear Medicine in Prostate Cancer: Current State and Future Perspectives 13
The Safety and Efficacy of Peptide Receptor Radionuclide Therapy for Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Single Center Experience 8
Expanding the long‑axial feld‑of‑view PET‑CT horizons: unveiling new arrows in our quiver 8
Current Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer 6
Alpha emitter isotopes and PSMA ligands: the near future therapeutic prospective for castration‑resistant prostate cancer 6
Long-axial-field of view in prostate cancer next generation imaging: the launch pad of theragnostic 6
Radiofrequency ablation versus radioactive iodine: the race for the best cure 5
Totale 691
Categoria #
all - tutte 4.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.304


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 0 0 0 0 0 3 0 0 1 1 0 3
2020/202144 1 0 5 3 12 6 2 2 2 2 4 5
2021/2022137 20 8 12 1 14 2 0 2 1 2 36 39
2022/2023148 13 7 5 4 15 18 2 12 19 35 12 6
2023/2024226 9 21 18 26 14 37 19 29 6 9 28 10
2024/2025128 52 29 8 3 36 0 0 0 0 0 0 0
Totale 691